19525. Adulteration and Misbranding of Ergotole. U. S. v. 286 Bottles of Ergotole. Default decree of condemnation, forfeiture, and de- struction. (F. & D. No. 27385. I. S. No. 42151. S. No. 5582.) Examination of the drug product Ergotole showed that it was represented to be standardized to the same potency as fluidextraet of ergot, whereas its potency was approximately one-third that of the pharmacopoeial requirement for fluidextraet of ergot. The article would not produce certain therapeutic Tesults claimed for it in the labeling, because of its low potency. On December 18, 1931, the United States attorney for the District of Colum-, bia, acting upon a report by the Secretary of Agriculture, filed in the Supreme* Court of the district aforesaid, holding a District Court, a libel praying seizure and condemnation of 286 bottles of Ergotole, remaining in the original unbroken, packages at Washington, D. C, alleging that the article had been shipped by Sharp & Dohme (Inc.), from Philadelphia, Pa., on or about October 6, 1931, and had been transported from the State of Pennsylvania into the District of Columbia, and charging adulteration and misbranding in violation of th» food and drugs act as amended. Adulteration of the article was alleged in the libel for the reason that it was sold under the following standard of strength, (carton and bottle label) " Ergotole * * * A Purified Liquid Preparation of Selected Ergot of Rye," (circular) "Ergotole is a liquid extract of Ergot of Rye, containing the oxy- tocic constituents of the drug * * * Ergotole is biologically assayed by the cock's comb method, and standardized to the same potency as the Fluid- extract of Ergot," whereas the strength of the article fell below such pro- fessed standard. Misbranding of the article was alleged for the reason that the following statements appearing in the labeling were false and misleading: (Carton and bottle labels) " Ergotole * * * A Purified Liquid Preparation of Selected Ergot of Rye;" (circular) "Ergotole is a liquid extract of Ergot of Rye, con- taining the oxytocic constituents of the drug. * * * Ergotole is biologically assayed by the cock's comb method, and standardized to the same potency as the Fluidextract of Ergot. The chief use for Ergotole is to excite uterine con- traction and to check uterine hemorrhage. It is therefore indicated for use in the third stage of labor. * * * Ergotole may be administered orally or hy- podermically. The suggested average dose for hypodermic administration is ten minims, and for oral administration thirty mimims." Misbranding of the article was alleged for the further reason that the statement. " The chief use for Ergotole is * * * to check uterine hemorrhage," appearing in the labeling regarding the curative or therapeutic effects of the article, was false and fraudulent, since it contained no ingredient or combination of ingredients | capable of producing the effects claimed. On March 28, 1932, no claimant having appeared for the property, judgment of condemnation and forfeiture was entered, and it was ordered by the court that the product be destroyed by the United States marshal. AETHTJB M. HYDE, Secretary of Agriculture.